Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	1434	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	1467	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	1691	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	1759	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	2352	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	2433	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	2484	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	2608	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	2805	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	2811	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	2817	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3159	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3258	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3267	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3458	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3484	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3499	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3608	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3674	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3897	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	3915	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	4133	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	4135	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	4468	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	4806	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	4936	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	6074	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	6398	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	6603	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	8526	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	8749	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	9415	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	9920	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	10169	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	10365	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	10624	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	10729	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	11029	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	12390	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	12670	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	12824	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	17586	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	18551	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	22365	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	29155	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]	85965	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	252996	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	263558	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	278511	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	301383	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	322511	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	325005	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	329425	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	334749	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	335010	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	336338	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	336849	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	338126	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	338547	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	339591	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	345463	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	347096	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	348062	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	353946	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	357071	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	357298	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	370670	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	373652	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	378642	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	386164	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	386781	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	391750	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	391931	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	392358	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	393221	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	397571	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	400154	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	401833	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	405391	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	405920	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	407958	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	408269	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	409409	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	411433	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	416016	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	418017	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	425477	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	425791	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	425978	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	431041	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	431870	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	435936	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	441838	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	447267	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	460996	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	463262	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	463888	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	465837	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	466645	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	468704	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	470206	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	471212	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	474759	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	475485	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	482527	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	502507	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	506649	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	508888	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	521953	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	523679	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	534583	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	539926	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	540731	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	541227	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	543822	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	545111	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	545362	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	547986	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	549932	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	561442	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	561811	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	571814	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	573777	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	588064	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	589803	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	600351	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	600874	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	601853	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	609956	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	619419	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	624703	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	627021	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	627509	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	636555	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	640444	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	662751	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	674813	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	677320	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	683431	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	689466	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	713959	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	830794	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	831981	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	861865	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-	954601	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUCOSE (CAS# 50-99-7); (M+CL)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	1197	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	1828	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	1941	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	2713	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	2999	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	3113	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	3132	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	3660	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	3836	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	3841	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	3886	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	3965	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	4106	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	4448	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	4465	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	4967	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	5115	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	5143	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	5191	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	5253	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUCOSE (CAS# 50-99-7); (2M+NA)+	5816	Peak area	Case	Y	Exemestane	White	Baseline	N	Y

Return to search page